High expression of CD47 can be observed on ovarian cancer, breast cancer, squamous cell carcinoma of the head and neck, gliomas, osteosarcoma, melanoma, glioblastoma, bladder cancer, colon cancer, hepatocellular cancer, and in myeloid leukemia stem cells. Here, CD47 is linked to myeloid leukemia.